Insider · CIK 0001400975

Weinhoff Gregory M

Reports to the SEC for 3 companies · CHESHIRE

sec.gov

Transactions

Companies

Filings

CIK

0001400975

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−65.9K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−584K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−230K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−31K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−125K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−100K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−123K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−320K sh	—	—	0
2026-03-26	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+24K sh	$3.85	+$92.4K	89,923
2026-03-26	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−24K sh	$30.00	−$720K	65,925
2026-03-26	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−24K sh	—	—	31,002
2026-03-13	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−61.3K sh	$26.17	−$1.6M	77,868
2026-03-13	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−11.9K sh	$27.16	−$324K	65,925
2026-02-02	Centessa Pharmaceuticals plcA Award	Chief Business Officer	AAward	+31K sh	—	—	139,121
2026-02-02	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Chief Business Officer	AAward	+123K sh	—	—	123,000
2026-02-01	Centessa Pharmaceuticals plcF Tax Payment	Chief Business Officer	FTax Payment	−14.2K sh	$24.57	−$348K	108,121
2025-07-25	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$3.85	+$38.5K	132,279
2025-07-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−10K sh	$15.56	−$156K	122,279
2025-07-25	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	55,000
2025-06-25	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$3.85	+$38.5K	132,279
2025-06-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−10K sh	$13.86	−$139K	122,279
2025-06-25	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	65,000
2025-05-27	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$3.85	+$38.5K	132,279
2025-05-27	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−10K sh	$12.82	−$128K	122,279
2025-05-27	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	75,000
2025-04-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−11.7K sh	$13.61	−$160K	122,279
2025-03-25	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$3.85	+$38.5K	144,021
2025-03-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−10K sh	$16.34	−$163K	134,021
2025-03-25	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	85,000
2025-02-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−11.5K sh	$15.25	−$175K	134,021
2025-02-03	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Chief Business Officer	AAward	+100K sh	—	—	100,000
2025-02-01	Centessa Pharmaceuticals plcF Tax Payment	Chief Business Officer	FTax Payment	−14.3K sh	$16.92	−$241K	145,515
2025-01-27	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−11.7K sh	$16.47	−$193K	159,782
2024-12-31	Centessa Pharmaceuticals plcF Tax Payment	Chief Business Officer	FTax Payment	−11.7K sh	$16.35	−$192K	171,524
2024-12-26	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$3.85	+$38.5K	193,266
2024-12-26	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−10K sh	$17.04	−$170K	183,266
2024-12-26	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	95,000
2024-11-25	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$3.85	+$38.5K	193,266
2024-11-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−10K sh	$17.66	−$177K	183,266
2024-11-25	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	105,000
2024-10-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−11.7K sh	$15.38	−$181K	183,266
2024-09-30	Centessa Pharmaceuticals plcF Tax Payment	Chief Business Officer	FTax Payment	−11.7K sh	$15.79	−$185K	195,008
2024-09-25	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−16.6K sh	$15.69	−$261K	206,750
2024-09-10	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+30K sh	$5.84	+$175K	253,369
2024-09-10	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−30K sh	$17.00	−$510K	223,369
2024-09-10	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−30K sh	—	—	584,321
2024-09-09	Centessa Pharmaceuticals plcM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+25K sh	$5.84	+$146K	248,369
2024-09-09	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−25K sh	$15.00	−$375K	223,369
2024-09-09	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−25K sh	—	—	614,321
2024-08-23	Centessa Pharmaceuticals plcS Sale	Chief Business Officer	SSale	−17.8K sh	$12.29	−$219K	223,369

Recent filings

Accepted (ET)
Jun 244
Weinhoff Gregory M0001470831-26-000610
SEC(opens sec.gov)
Mar 264
Weinhoff Gregory M0001470831-26-000320
SEC(opens sec.gov)
Mar 134
Weinhoff Gregory M0001470831-26-000267
SEC(opens sec.gov)
Feb 34
Weinhoff Gregory M0001470831-26-000090
SEC(opens sec.gov)
Jul 254
Weinhoff Gregory M0001847903-25-000123
SEC(opens sec.gov)
Jun 254
Weinhoff Gregory M0001847903-25-000115
SEC(opens sec.gov)

Companies

Address

C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM

CHESHIRE, WA14 2DT